Absence of Anti- < i > Babesia microti < /i > antibody in commercial intravenous immunoglobulin (IVIG)

ConclusionsCommercially available IVIG may not be of therapeutic benefit for babesiosis patients. Additional sampling of IVIG for B. microti antibody and a clinical trial of babesiosis patients given IVIG compared with controls would provide further insight into the use of IVIG for the treatment of babesiosis.
Source: PLoS Neglected Tropical Diseases - Category: Tropical Medicine Authors: Source Type: research